Region: Czech Republic

A Swiss investor has threatened Romania with a treaty claim, saying its interest in a now-bankrupt road infrastructure company was destroyed by tax decisions and asset seizures imposed by the state authorities. 

16 April 2025

An ICSID annulment committee has upheld an award that threw out a US$235 million damages claim against the Czech Republic over a residential development even though the state was found liable.

11 March 2025

Czech energy group CEZ says it has won more than €42 million in an ICC claim against Gazprom’s export arm over its curtailment of gas supplies following Russia’s full-scale invasion of Ukraine. 

26 February 2025

An UNCITRAL tribunal has rejected an Israeli businessman’s treaty claim over the alleged expropriation of real estate development plots, finding that the land belongs to a Catholic religious order.

16 January 2025

UPDATED: Three European renewable energy companies have threatened to bring an Energy Charter Treaty claim against the Czech Republic in response to “destructive” proposals to reduce state subsidies for solar photovoltaic plants.

06 November 2024

A Czech state-owned entity says it has won a €113 million Prague arbitration against Gazprom’s exports arm over missed payments under gas transportation contracts.

13 September 2024

A UK court has dismissed the Czech Republic’s remaining challenges to a US$750 million treaty award won by investors in a blood plasma business, having previously upheld one ground raised by the state.

09 August 2024

The Swiss Federal Supreme Court has upheld an investment treaty award ordering the Czech Republic to pay European investors US$15 million over the state’s reforms to its solar legislation.

12 July 2024

An English judge has refused to allow the Czech Republic to amend its challenge to a US$730 million treaty award over a blood plasma business to introduce a new objection based on the multiple nationalities of one of the claimants.  

28 March 2024

A UK court has upheld one of the Czech Republic’s grounds of challenge to a US$730 million treaty award won by investors in a blood plasma business, while dismissing or reserving judgment on other objections.

08 March 2024